trans-4-hydroxytamoxifen ( 4-ohtam ) , a very active metabolite of the antiestrogen tamoxifen , was percutaneously administered to the affected breast of nine patients before surgery for breast cancer in order to evaluate 4-ohtam absorption through the skin and its subcellular localization and metabolism .
C0006141
breast
C0006142
breast cancer